Benefits of antiretroviral therapy initiation during acute HIV infection

被引:20
作者
De Clercq, Jozefien [1 ,2 ,3 ]
Rutsaert, Sofie [1 ]
De Scheerder, Marie-Angelique [2 ]
Verhofstede, Chris [3 ]
Callens, Steven [2 ]
Vandekerckhove, Linos [1 ,2 ]
机构
[1] Univ Ghent, Dept Internal Med & Pediat, HIV Cure Res Ctr, Ghent, Belgium
[2] Ghent Univ Hosp, Dept Gen Internal Med & Infect Dis, Ghent, Belgium
[3] Ghent Univ Hosp, AIDS Reference Lab, Ghent, Belgium
关键词
Acute HIV infection; acute retroviral syndrome; early antiretroviral therapy; treatment as prevention; HIV cure; ACTIVATION; VIREMIA;
D O I
10.1080/17843286.2020.1770413
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives In the last decade, there has been increasing scientific and legislative focus on antiretroviral treatment (ART) for all people living with HIV. Especially early ART initiation, preferably during acute HIV infection, has been named as a promising strategy, both for the individual and for the society. This article will review the benefits and possible future applications of immediate ART initiation during acute HIV infection and explore the remaining hurdles towards this strategy. Results On an individual level, initiation of ART during acute HIV infection limits the viral reservoir, preserves immune function, and decreases systemic inflammation. In addition, obtaining viral suppression soon after infection can be beneficial for the society by decreasing the chance of onward HIV transmission. Reducing the transmission will reduce HIV incidence and can curtail HIV-related health expenditure. Furthermore, the favorable immunological and virological profile obtained by treating during acute HIV infection will form an ideal starting point for several HIV cure strategies. Conclusions Initiation of ART during acute HIV infection has shown distinct benefits for the individual, for the society, and for future research on HIV cure. In order to implement this strategy, equal focus should be placed on early diagnosis.
引用
收藏
页码:168 / 176
页数:9
相关论文
共 73 条
  • [1] HIV "shock and kill" therapy: In need of revision
    Abner, Erik
    Jordan, Albert
    [J]. ANTIVIRAL RESEARCH, 2019, 166 : 19 - 34
  • [2] Myeloid and CD4 T Cells Comprise the Latent Reservoir in Antiretroviral Therapy-Suppressed SIVmac251-Infected Macaques
    Abreu, Celina M.
    Veenhuis, Rebecca T.
    Avalos, Claudia R.
    Graham, Shelby
    Parrilla, Daymond R.
    Ferreira, Edna A.
    Queen, Suzanne E.
    Shirk, Erin N.
    Bullock, Brandon T.
    Li, Ming
    Pate, Kelly A. Metcalf
    Beck, Sarah E.
    Mangus, Lisa M.
    Mankowski, Joseph L.
    Mac Gabhann, Feilim
    O'Connor, Shelby L.
    Gama, Lucio
    Clements, Janice E.
    [J]. MBIO, 2019, 10 (04):
  • [3] Higher Baseline CD4 Cell Count Predicts Treatment Interruptions and Persistent Viremia in Patients Initiating ARVs in Rural Uganda
    Adakun, Susan A.
    Siedner, Mark J.
    Muzoora, Conrad
    Haberer, Jessica E.
    Tsai, Alexander C.
    Hunt, Peter W.
    Martin, Jeff N.
    Bangsberg, David R.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 62 (03) : 317 - 321
  • [4] Impact of Multi-Targeted Antiretroviral Treatment on Gut T Cell Depletion and HIV Reservoir Seeding during Acute HIV Infection
    Ananworanich, Jintanat
    Schuetz, Alexandra
    Vandergeeten, Claire
    Sereti, Irini
    de Souza, Mark
    Rerknimitr, Rungsun
    Dewar, Robin
    Marovich, Mary
    van Griensven, Frits
    Sekaly, Rafick
    Pinyakorn, Suteeraporn
    Phanuphak, Nittaya
    Trichavaroj, Rapee
    Rutvisuttinunt, Wiriya
    Chomchey, Nitiya
    Paris, Robert
    Peel, Sheila
    Valcour, Victor
    Maldarelli, Frank
    Chomont, Nicolas
    Michael, Nelson
    Phanuphak, Praphan
    Kim, Jerome H.
    [J]. PLOS ONE, 2012, 7 (03):
  • [5] Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial
    Baker, Jason V.
    Sharma, Shweta
    Achhra, Amit C.
    Ignacio Bernardino, Jose
    Bogner, Johannes R.
    Duprez, Daniel
    Emery, Sean
    Gazzard, Brian
    Gordin, Jonathan
    Grandits, Greg
    Phillips, Andrew N.
    Schwarze, Siegfried
    Soliman, Elsayed Z.
    Spector, Stephen A.
    Tambussi, Giuseppe
    Lundgren, Jens
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (05):
  • [6] Immunologic strategies for HIV-1 remission and eradication
    Barouch, Dan H.
    Deeks, Steven G.
    [J]. SCIENCE, 2014, 345 (6193) : 169 - 174
  • [7] Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
    Barouch, Dan H.
    Whitney, James B.
    Moldt, Brian
    Klein, Florian
    Oliveira, Thiago Y.
    Liu, Jinyan
    Stephenson, Kathryn E.
    Chang, Hui-Wen
    Shekhar, Karthik
    Gupta, Sanjana
    Nkolola, Joseph P.
    Seaman, Michael S.
    Smith, Kaitlin M.
    Borducchi, Erica N.
    Cabral, Crystal
    Smith, Jeffrey Y.
    Blackmore, Stephen
    Sanisetty, Srisowmya
    Perry, James R.
    Beck, Matthew
    Lewis, Mark G.
    Rinaldi, William
    Chakraborty, Arup K.
    Poignard, Pascal
    Nussenzweig, Michel C.
    Burton, Dennis R.
    [J]. NATURE, 2013, 503 (7475) : 224 - +
  • [8] Reassessment of HIV-1 Acute Phase Infectivity: Accounting for Heterogeneity and Study Design with Simulated Cohorts
    Bellan, Steve E.
    Dushoff, Jonathan
    Galvani, Alison P.
    Meyers, Lauren Ancel
    [J]. PLOS MEDICINE, 2015, 12 (03)
  • [9] Frequency and Spectrum of Unexpected Clinical Manifestations of Primary HIV-1 Infection
    Braun, Dominique L.
    Kouyos, Roger D.
    Balmer, Belinda
    Grube, Christina
    Weber, Rainer
    Guenthard, Huldrych F.
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 61 (06) : 1013 - 1021
  • [10] A Novel Acute Retroviral Syndrome Severity Score Predicts the Key Surrogate Markers for HIV-1 Disease Progression
    Braun, Dominique L.
    Kouyos, Roger
    Oberle, Corinna
    Grube, Christina
    Joos, Beda
    Fellay, Jacques
    McLaren, Paul J.
    Kuster, Herbert
    Guenthard, Huldrych F.
    [J]. PLOS ONE, 2014, 9 (12):